STK11 genotyping and cancer risk in Peutz-Jeghers syndrome

The estimated relative cancer risk may be 15 fold higher than in the general population 1 and appears to be particularly high in women (20 fold) because of an increased risk of development of breast cancer and gynaecological malignancies. 2 Germline mutations in the STK11/LKB1 gene on 19p13.3 are fo...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical genetics Vol. 42; no. 5; pp. 428 - 435
Main Authors Schumacher, V, Vogel, T, Leube, B, Driemel, C, Goecke, T, Möslein, G, Royer-Pokora, B
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.05.2005
BMJ
BMJ Publishing Group LTD
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The estimated relative cancer risk may be 15 fold higher than in the general population 1 and appears to be particularly high in women (20 fold) because of an increased risk of development of breast cancer and gynaecological malignancies. 2 Germline mutations in the STK11/LKB1 gene on 19p13.3 are found in 30-70% of PJS cases, depending on the screening method, with considerable uncharacterised genetic heterogeneity remaining in this syndrome. 3, 4 The disease causing gene has been identified by two independent groups. 5, 6 Human STK11 encodes a serine/threonine protein kinase that is highly homologous to the mouse protein Lkb1 and the Xenopus kinase XEEK1, 7, 8 and is expressed in all human tissues. 9 The kinase domain of the human 433 amino acid protein is localised between residues 49 and 309, 7 and shows homology to the conserved catalytic core of the kinase domain common to both serine/threonine and tyrosine protein kinase family members. 10 Most mutations found in PJS patients are small deletions/insertions or single base substitutions leading to an abnormal truncated/kinase inactive protein. PJS is a cancer predisposing disorder; however, cancer risk may vary. [...]we studied whether specific STK11 mutations may confer a lower or higher cancer risk in PJS patients by examining the site and type of mutations with regard to cancer frequency and cancer type.
Bibliography:ark:/67375/NVC-05MT7TSQ-S
local:0420428
PMID:15863673
href:jmedgenet-42-428.pdf
Correspondence to:
 Dr. Valérie Schumacher
 Heinrich-Heine Universitaet Düsseldorf, Institut für Humangenetik und Anthropologie, Universitaetsstrasse 1, D-40225 Düsseldorf; schumacv@uni-duesseldorf.de
istex:D0A21E18B79525CBC290B7C821F5D7B8AECC5649
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0022-2593
1468-6244
1468-6244
DOI:10.1136/jmg.2004.026294